Table 2 Univariate and multivariate Cox analyses on variables for the prediction of overall survival of NM-GBA patients.

Sex

Female

Reference

Male

1.275 (1.055–1.541)

1.414 (1.153–1.735)

Race

White

Reference

Black

0.803 (0.606–1.066)

1.013 (0.757–1.355)

Other

0.750 (0.563–0.999)

0.963 (0.715–1.298)

Grade

G1

Reference

G2

1.539 (1.155–2.051)

1.320 (0.978–1.780)

G3

1.982 (1.479–2.657)

1.350 (0.987–1.847)

G4

3.075 (1.466–6.448)

2.250 (1.056–4.796)

T

T1

Reference

T2

1.286 (0.937–1.764)

0.604 (0.302–1.210)

T3

2.722 (1.973–3.754)

1.123 (0.559–2.253)

T4

4.883 (2.901–8.221)

0.944 (0.381–2.339)

Stage

Stage I

Reference

Stage II

1.046 (0.719–1.522)

1.635 (0.740–3.612)

Stage III

2.781 (1.977–3.913)

2.042 (0.937–4.452)

Stage IV

4.855 (3.092–7.622)

4.271 (1.745–10.453)

Radiation

None

Reference

Yes

0.960 (0.788–1.169)

0.813 (0.636–1.039)

Chemotherapy

None

Reference

Yes

0.954 (0.798–1.141)

0.770 (0.606–0.979)

LODDS

LODDS1

Reference

LODDS2

1.899 (1.511–2.387)

1.792 (1.405–2.286)

LODDS3

4.244 (3.313–5.436)

3.221 (2.373–4.371)

Size (mm)

1–13

Reference

14–56

2.040 (1.521–2.737)

1.487 (1.091–2.028)

57–160

3.446 (2.412–4.923)

2.254 (1.540–3.297)

Age (years)

29–72

Reference

73–82

1.712 (1.402–2.090)

1.601 (1.289–1.988)

83–100

2.630 (2.043–3.384)

1.908 (1.421–2.562)

Marital

Married

Reference

Single

0.954 (0.721–1.263)

1.193 (0.889–1.599)

Separated

1.000 (0.751–1.331)

1.055 (0.778–1.429)

Widowed

1.498 (1.208–1.858)

1.222 (0.958–1.558)